Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.73 |
| ▸ | NPC1 | O15118 | 3/20 | 0.64 |
| ▸ | RAB9A | P51151 | 3/20 | 0.64 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | THRA | P10827 | 3/20 | 0.58 |
| ▸ | THRB | P10828 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | CASP3 | P42574 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.56 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.56 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.56 |
| ▸ | F13A1 | P00488 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5546226 | 0.95 | POLB (0.66) | POLBNPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL11297385 | 0.93 | THRA (0.68) | POLBCA12CA1CA2CA9 | |
| SCHEMBL3027338 | 0.93 | THRA (0.68) | POLBCA12CA1CA2CA9 | |
| SCHEMBL6746649 | 0.93 | THRA (0.68) | POLBCA12CA1CA2CA9 | |
| SCHEMBL18405961 | 0.91 | POLB (0.61) | POLBNPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL1902060 | 0.90 | SMN1; SMN2 (0.59) | POLBNPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL11116153 | 0.90 | SMN1; SMN2 (0.59) | POLBNPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL7211903 | 0.89 | AOC3 (0.61) | POLBRAB9AHPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL2019464 | 0.87 | POLB (0.70) | POLBNPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL15094124 | 0.87 | CA12 (0.74) | POLBNPC1RAB9AHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023065014-A1 | CONJUGATES COMPRISING ANTIFUNGALS AND HEAT SHOCK PROTEIN 90 (HSP90) INHIBITORS AND METHODS OF USE THEREOF | BRIGHT ANGEL THERAPEUTICS INC. (CA) | 2023-04-27 | — | — | WO | disclosed |
| CN-112574054-B | Efficient nitriding reagent and application thereof | 北京大学 | 2022-10-14 | — | — | CN | disclosed |
| US-11254686-B1 | Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor | CORVUS PHARMACEUTICALS, INC. (US) | 2022-02-22 | — | — | US | disclosed |
| CN-112574054-A | Efficient nitriding reagent and application thereof | 北京大学 | 2021-03-30 | — | — | CN | disclosed |
| EP-2766474-B1 | INHIBITION AND ENHANCEMENT OF REPROGRAMMING BY CHROMATIN MODIFYING ENZYMES | CHILDRENS MEDICAL CENTER (US) | 2020-10-07 | — | — | EP | disclosed |
| EP-2509600-B1 | THERAPEUTICALLY ACTIVE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER CHARACTERIZED AS HAVING AN IDH MUTATION | AGIOS PHARMACEUTICALS INC (US) | 2017-08-02 | — | — | EP | disclosed |
| US-20170166541-A1 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE | SERVIER PHARMACEUTICALS LLC | 2017-06-15 | — | — | US | disclosed |
| US-20170166541-A1 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE | SERVIER PHARMACEUTICALS LLC | 2017-06-15 | — | — | US | disclosed |
| US-20170014419-A1 | MEDICAMENT FOR SUPPRESSING MALIGNANT TUMOR METASTASIS | NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER (JP) | 2017-01-19 | — | — | US | disclosed |
| CN-105541740-A | 5-n-butyl-1H-benzotriazole synthesis process | ZHAO JIANYING | 2016-05-04 | — | — | CN | disclosed |
| EP-0650955-A1 | Amine compound and electro-luminescence device comprising same | HODOGAYA CHEMICAL CO., LTD. (JP) | 1995-05-03 | — | — | EP | disclosed |
| EP-0622359-A1 | Quinoxaline compound, liquid crystal composition containing the compound, liquid crystal device using the composition, display apparatus and display method | CANON KABUSHIKI KAISHA (JP) | 1994-11-02 | — | — | EP | disclosed |
| EP-0010231-B1 | POLYPHOSPHAZENE POLYMERS CONTAINING N-SUBSTITUTED AMIDO AND IMIDO SUBSTITUENTS AND PROCESS FOR THEIR PREPARATION | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1982-12-15 | — | — | EP | disclosed |
| EP-0039367-A4 | UV-ABSORBING COMPOUNDS AND PHOTOGRAPHIC ELEMENTS CONTAINING THEM. | MINNESOTA MINING & MFG (US) | 1982-07-12 | — | — | EP | disclosed |
| US-4323633-A | BUTYLATED 2-HYDROXYPHENYL BENZOTRIAZOLE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-04-06 | — | — | US | disclosed |
| EP-0039367-A1 | UV-ABSORBING COMPOUNDS AND PHOTOGRAPHIC ELEMENTS CONTAINING THEM | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1981-11-11 | — | — | EP | disclosed |
| WO-1981001473-A1 | UV-ABSORBING COMPOUNDS AND PHOTOGRAPHIC ELEMENTS CONTAINING THEM | MINNESOTA MINING & MFG (US) | 1981-05-28 | — | — | WO | disclosed |
| US-4218557-A | PROTECTIVE COATINGS, MOLDINGS, FOAMS | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1980-08-19 | — | — | US | disclosed |
| EP-0010231-A1 | Polyphosphazene polymers containing N-substituted amido and imido substituents and process for their preparation | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1980-04-30 | — | — | EP | disclosed |
| US-4060491-A | 5-ALKYL BENZOTRIAZOLE | MOBIL OIL CORPORATION (US) | 1977-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11254686-B1 | Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor | ADORA2A, ADORA2B, ADORA3 | POLB 1881/4885NPC1 2573/4885RAB9A 2070/4885 |
| US-20170166541-A1 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE | MCL1, TP53, CD44 | POLB 356/4885NPC1 927/4885RAB9A 1957/4885 |
| US-20170014419-A1 | MEDICAMENT FOR SUPPRESSING MALIGNANT TUMOR METASTASIS | AGTR2, MME, AGTR1 | POLB 4812/4885NPC1 2415/4885RAB9A 3461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.